How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer

72Citations
Citations of this article
193Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: To investigate how COVID-19 fear and anxiety (COV-FA) affects chemotherapy adherence in patients with cancer. Materials & methods: The records of 3661 patients with chemotherapy (CT) appointments were retrospectively reviewed. Results: The CT postponement rates before and after COVID-19 were 11.6% and 14.2%, respectively (p = 0.017). The rate of COV-FA-related CT postponement after telemedicine was lower than that before (4.6% vs 17.4%; p = 0.012). The median time to come back to treatment of the COV-FA group was 47 days (range 19-72 days). Advanced age (≥60 years) was found to be the independent factor that was predictive of time to come back to treatment (p = 0.043). Conclusion: The CT postponement rate increased after COVID-19. COV-FA-related CT postponement decreased after telemedicine. Advanced age could be predictive of time to come back to treatment.

Cite

CITATION STYLE

APA

Karacin, C., Bilgetekin, I., B Basal, F., & Oksuzoglu, O. B. (2020). How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncology, 16(29), 2283–2293. https://doi.org/10.2217/fon-2020-0592

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free